Ako Hosono

1.5k total citations
52 papers, 963 citations indexed

About

Ako Hosono is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ako Hosono has authored 52 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 10 papers in Surgery. Recurrent topics in Ako Hosono's work include Sarcoma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (8 papers) and HER2/EGFR in Cancer Research (6 papers). Ako Hosono is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (8 papers) and HER2/EGFR in Cancer Research (6 papers). Ako Hosono collaborates with scholars based in Japan, United States and United Kingdom. Ako Hosono's co-authors include Hideo Mugishima, Shigeharu Hosono, Hidetoshi Fujita, Michiyoshi Minato, Akira Kawai, Tomoo Okada, Shori Takahashi, Keita Harada, Atsushi Makimoto and Nobuaki Matsubara and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Ako Hosono

48 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ako Hosono Japan 17 606 265 188 184 157 52 963
Daniel A. Rushing United States 20 771 1.3× 564 2.1× 283 1.5× 87 0.5× 270 1.7× 42 1.5k
N. Doumerc France 21 749 1.2× 154 0.6× 486 2.6× 73 0.4× 735 4.7× 98 1.6k
E. Cohen United States 16 323 0.5× 189 0.7× 205 1.1× 19 0.1× 195 1.2× 43 1.1k
Masayuki Iwazaki Japan 15 358 0.6× 199 0.8× 170 0.9× 14 0.1× 156 1.0× 92 718
Cheol Yong Yoon South Korea 21 455 0.8× 125 0.5× 336 1.8× 39 0.2× 220 1.4× 67 1.1k
Martijn G. Steffens Netherlands 16 327 0.5× 132 0.5× 205 1.1× 22 0.1× 275 1.8× 54 867
Costantine Albany United States 21 537 0.9× 367 1.4× 1.1k 5.7× 79 0.4× 445 2.8× 89 1.7k
Haiyan Wang China 14 320 0.5× 227 0.9× 85 0.5× 35 0.2× 159 1.0× 54 939
Désirée Tampe Germany 17 333 0.5× 283 1.1× 127 0.7× 48 0.3× 612 3.9× 46 1.4k
Agnese Barnabei Italy 18 175 0.3× 706 2.7× 137 0.7× 45 0.2× 165 1.1× 35 1.2k

Countries citing papers authored by Ako Hosono

Since Specialization
Citations

This map shows the geographic impact of Ako Hosono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ako Hosono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ako Hosono more than expected).

Fields of papers citing papers by Ako Hosono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ako Hosono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ako Hosono. The network helps show where Ako Hosono may publish in the future.

Co-authorship network of co-authors of Ako Hosono

This figure shows the co-authorship network connecting the top 25 collaborators of Ako Hosono. A scholar is included among the top collaborators of Ako Hosono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ako Hosono. Ako Hosono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirota, Akira, Nobuyuki Takahashi, Hiromichi Nakajima, et al.. (2023). The impact of the COVID‐19 pandemic on perioperative chemotherapy for breast cancer. Cancer Medicine. 12(11). 12095–12105. 3 indexed citations
2.
Kunisada, Toshiyuki, Eiji Nakata, Tomohiro Fujiwara, et al.. (2022). Soft-tissue sarcoma in adolescents and young adults. International Journal of Clinical Oncology. 28(1). 1–11. 24 indexed citations
3.
Naito, Yoichi, Hiromichi Nakajima, Chihiro Kondoh, et al.. (2022). Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study. Japanese Journal of Clinical Oncology. 53(2). 105–114. 2 indexed citations
4.
Nakajima, Hiromichi, Kenichi Harano, Tokiko Nakai, et al.. (2022). Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer. The Breast. 61. 136–144. 11 indexed citations
5.
Naito, Yoichi, Shogo Nomura, Masashi Wakabayashi, et al.. (2022). Impact of Older Age and Medico-social Factors on the Decision to Offer Adjuvant Chemotherapy to Patients With Breast Cancer. Anticancer Research. 42(7). 3743–3751.
6.
Mukohara, Toru, Miki Kondo, Kazushi Maruo, et al.. (2022). Effectiveness of an online support program to help female cancer patients manage their health and illness: Protocol for a randomized controlled trial. Contemporary Clinical Trials Communications. 30. 101035–101035. 2 indexed citations
7.
Mukohara, Toru, Ako Hosono, Sachiyo Mimaki, et al.. (2021). Effects of Ado-Trastuzumab Emtansine and Fam-Trastuzumab Deruxtecan on Metastatic Breast Cancer Harboring HER2 Amplification and the L755S Mutation. The Oncologist. 26(8). 635–639. 12 indexed citations
8.
Naito, Yoichi, Chihiro Kondoh, Kenichi Harano, et al.. (2021). The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis. The Breast. 58. 50–56. 6 indexed citations
9.
Shingaki, Sumito, Takahiro Kogawa, Mototsugu Shimokawa, et al.. (2020). Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer. Journal of Cancer. 11(14). 4099–4105. 3 indexed citations
10.
Matsubara, Nobuaki, et al.. (2017). Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer. Cancer Chemotherapy and Pharmacology. 80(6). 1063–1072. 24 indexed citations
11.
Doi, Toshihiko, Kohei Shitara, Yoichi Naito, et al.. (2016). Phase I dose escalation (esc) trial of weekly intravenous (i.v.) BI 836845 in Japanese patients (pts) with advanced solid tumors. Annals of Oncology. 27. vi119–vi119. 2 indexed citations
12.
Yasui, N, Hiroshi Kawamoto, Megumi Fujiwara, et al.. (2014). High-dose chemotherapy for high-risk retinoblastoma: clinical course and outcome of 14 cases in the National Cancer Center, Japan. Bone Marrow Transplantation. 50(2). 221–224. 3 indexed citations
13.
Kojima, Yuki, Kenji Hashimoto, Masashi Ando, et al.. (2012). Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis. Cancer Chemotherapy and Pharmacology. 70(3). 391–397. 15 indexed citations
14.
Momota, Hiroyuki, et al.. (2010). Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation. Pediatric Blood & Cancer. 55(3). 577–579. 19 indexed citations
15.
Kikuta, Kazutaka, Naobumi Tochigi, Tadakazu Shimoda, et al.. (2009). Nucleophosmin as a Candidate Prognostic Biomarker of Ewing's Sarcoma Revealed by Proteomics. Clinical Cancer Research. 15(8). 2885–2894. 43 indexed citations
16.
Yonemori, Kan, Umio Yamaguchi, Masayuki Kaneko, et al.. (2007). Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population. Journal of Cancer Research and Clinical Oncology. 134(3). 389–395. 5 indexed citations
17.
Hosono, Ako, Umio Yamaguchi, Atsushi Makimoto, et al.. (2006). Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma. Journal of Clinical Pathology. 60(4). 410–414. 11 indexed citations
18.
Kawai, Akira, Ako Hosono, Robert Nakayama, et al.. (2006). Clear cell sarcoma of tendons and aponeuroses. Cancer. 109(1). 109–116. 93 indexed citations
19.
Hosono, Shigeharu, Ako Hosono, Hideo Mugishima, et al.. (2006). Successful recombinant erythropoietin therapy for a developing anemic newborn with hereditary spherocytosis. Pediatrics International. 48(2). 178–180. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel A. Rushing Breakdown of academic impact, for papers by N. Doumerc Breakdown of academic impact, for papers by E. Cohen Breakdown of academic impact, for papers by Masayuki Iwazaki Breakdown of academic impact, for papers by Cheol Yong Yoon Breakdown of academic impact, for papers by Martijn G. Steffens Breakdown of academic impact, for papers by Costantine Albany Breakdown of academic impact, for papers by Haiyan Wang Breakdown of academic impact, for papers by Désirée Tampe Breakdown of academic impact, for papers by Agnese Barnabei
Rankless by CCL
2026